Skip to main content

Peer Review reports

From: Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies

Original Submission
24 Jun 2021 Submitted Original manuscript
1 Aug 2021 Reviewed Reviewer Report
9 Aug 2021 Reviewed Reviewer Report
16 Aug 2021 Reviewed Reviewer Report
13 Sep 2021 Author responded Author comments - Abhinav K Misra
Resubmission - Version 2
13 Sep 2021 Submitted Manuscript version 2
5 Oct 2021 Reviewed Reviewer Report
17 Oct 2021 Reviewed Reviewer Report
20 Oct 2021 Reviewed Reviewer Report
30 Oct 2021 Author responded Author comments - Abhinav K Misra
Resubmission - Version 3
30 Oct 2021 Submitted Manuscript version 3
Publishing
4 Nov 2021 Editorially accepted
14 Nov 2021 Article published 10.1186/s12890-021-01737-7

You can find further information about peer review here.

Back to article page